Cefonicid
Pharmacokinetic studies of Cefonicid have shown that high blood concentrations can be achieved rapidly after intravenous and intramuscular injection, and that concomitant use of albendazole prolongs its half-life in the body and reduces the rate of renal excretion[1].
Product Specifications
CAS Number
61270-58-4
UNSPSC
12352005
Hazard Statement
H302-H312-H332
Target
Bacterial
Type
Reference compound
Related Pathways
Anti-infection
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/cefonicid.html
Smiles
O=C(O)C(N12)=C(CSC3=NN=NN3CS(=O)(O)=O)CS[C@]2([H])[C@H](NC([C@H](O)C4=CC=CC=C4)=O)C1=O
Molecular Formula
C18H18N6O8S3
Molecular Weight
542.57
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P330-P363-P501
References & Citations
[1]Pitkin D, et al. Kinetics and renal handling of cefonicid[J]. Clinical Pharmacology & Therapeutics, 1981, 30 (5) : 587-593.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Launched
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Anti-Purple sea urchin Wnt8-S Antibody Fluoro488 Conjugated
